On the other hand, genome-wide association studies (GWAS) revealed that common variants in the UMOD promoter region, which drive variable expression levels of uromodulin, are linked with increased risks of chronic kidney disease, calcium stones and hypertension in the general population4–6. Here, UMOD is linked to Hypertension.